Caidya partnered with a U.S. based biotech company to enable and accelerate clinical development in China across Investigator-Initiated Trials (IITs) and IND studies in autoimmune disease.
Back to Resource Center
Caidya partnered with a U.S. based biotech company to enable and accelerate clinical development in China across Investigator-Initiated Trials (IITs) and IND studies in autoimmune disease.